SOSV

SOSV, established in 1995 and headquartered in Princeton, New Jersey, is a global venture capital firm specializing in early-stage investments. It focuses on deep tech innovations in the health and environmental sectors, supporting founders with breakthrough technologies through its HAX and IndieBio startup development programs. SOSV provides resources, facilities, and lab equipment to accelerate product development and scale, with a track record of helping its portfolio companies secure subsequent funding rounds led by top-tier investors.

Hugh Bowen

Associate

Navin Danapal

Director, South East Asia

Weichang Ge

Analyst

Bradford Higgins

Venture Partner

Katie Hoffman

General Partner

Mohan Iyer

General Partner

Benjamin Joffe

Partner

Ji Ke

Partner

Stephen McCann

CFO and General Partner

Carthach McCarthy

CFO

Paul Monaghan

Principal

Brian Murphy

Finance Director

Eric Ramsay

Analyst

Sabriya Stukes Ph.D

Partner

Past deals in Massachussets

Gatehouse Bio

Convertible Note in 2024
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Lura Health

Seed Round in 2023
Lura Health is a pioneering company that has developed a non-invasive continuous health monitoring platform utilizing saliva as a diagnostic fluid. Founded in 2017 and headquartered in Cambridge, Massachusetts, the company focuses on chronic disease management, targeting conditions such as heart disease, chronic kidney disease, diabetes, and tooth decay. Lura Health's innovative sensors are designed to be integrated into patient-friendly orthodontic devices, including removable retainers and fixed brackets. These sensors continuously monitor oral acidity and other analytes in saliva, automatically transmitting valuable health data to a mobile application. This approach empowers users to track key diagnostic metrics within their oral environment, facilitating improved personal health management and potentially enhancing clinical outcomes.

Gatehouse Bio

Convertible Note in 2023
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Pear Bio

Series A in 2023
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Pear Bio

Convertible Note in 2023
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

BioROSA Technologies

Convertible Note in 2022
BioROSA Technologies Inc. is a biotechnology company focused on developing diagnostic tools for Autism Spectrum Disorders (ASD). Founded in 2018 and headquartered in Belmont, Massachusetts, the company specializes in creating biologically-based blood tests that assist clinicians in identifying individuals at risk for ASD. By utilizing machine learning to analyze biological data, BioROSA Technologies aims to provide reliable and accurate diagnoses, facilitating early detection and timely treatment. Additionally, the company's technology supports therapeutic trials by evaluating pharmacodynamics and patient stratification, thereby enhancing the overall standard of care for ASD.

Harmony Baby Nutrition

Seed Round in 2022
Harmony is a biotechnology startup that creates human breast milk protein-based infant nutrition designed to help human babies thrive. It is the world’s first dairy-free, allergen-free and environmentally friendly infant nutrition. Harmony Baby Nutrition was established in 2018 and is based in Boston, MA.

Gatehouse Bio

Seed Round in 2022
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Prospective Research

Convertible Note in 2022
Prospective Research, Inc., based in Beverly, Massachusetts, specializes in developing innovative solutions for antibiotic discovery and disease management in aquaculture. Founded in 2015, the company utilizes its proprietary MicrobeMiner platform to access untapped antibiotics by mimicking natural soil stimuli. Its GeneMiner technology aligns specific microbes with targeted stimuli, while the StimKeys technology reproduces these stimuli to unlock microbial natural products. Additionally, Prospective Research is pioneering feed-integrated preventative disease management solutions that eliminate the need for traditional antibiotics in aquaculture. By employing microbial signaling molecules, the company can modulate bacterial behavior and deliver therapeutics directly to the gut of farmed species. Prospective Research introduces trillions of beneficial bacteria into the microbiome of fin-fish, shrimp, and shellfish, enabling selective activation of bacterial genes that produce bio-active therapeutics to combat various pathogens.

Gatehouse Bio

Convertible Note in 2022
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Cellens

Convertible Note in 2022
Cellens is a medical device company based in Medford, Massachusetts, and is a spinoff from Tufts University, established in 2019. The company focuses on enhancing cancer detection through noninvasive screening methods. It has developed a cell surface scanning platform that utilizes atomic force microscopy imaging and machine learning to assist oncologists in the detection of bladder cancer. By analyzing physio-biomarkers on cell surfaces derived from urine samples, Cellens provides a diagnostic score that helps healthcare professionals minimize the need for invasive and costly procedures, thereby improving patient outcomes in bladder cancer diagnostics.

Cellens

Seed Round in 2022
Cellens is a medical device company based in Medford, Massachusetts, and is a spinoff from Tufts University, established in 2019. The company focuses on enhancing cancer detection through noninvasive screening methods. It has developed a cell surface scanning platform that utilizes atomic force microscopy imaging and machine learning to assist oncologists in the detection of bladder cancer. By analyzing physio-biomarkers on cell surfaces derived from urine samples, Cellens provides a diagnostic score that helps healthcare professionals minimize the need for invasive and costly procedures, thereby improving patient outcomes in bladder cancer diagnostics.

Gatehouse Bio

Seed Round in 2021
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Synthace

Series C in 2021
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Catalog

Series B in 2021
Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

Pear Bio

Seed Round in 2021
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

BioROSA Technologies

Convertible Note in 2021
BioROSA Technologies Inc. is a biotechnology company focused on developing diagnostic tools for Autism Spectrum Disorders (ASD). Founded in 2018 and headquartered in Belmont, Massachusetts, the company specializes in creating biologically-based blood tests that assist clinicians in identifying individuals at risk for ASD. By utilizing machine learning to analyze biological data, BioROSA Technologies aims to provide reliable and accurate diagnoses, facilitating early detection and timely treatment. Additionally, the company's technology supports therapeutic trials by evaluating pharmacodynamics and patient stratification, thereby enhancing the overall standard of care for ASD.

Synthace

Convertible Note in 2021
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Gatehouse Bio

Funding Round in 2021
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Harmony Baby Nutrition

Seed Round in 2021
Harmony is a biotechnology startup that creates human breast milk protein-based infant nutrition designed to help human babies thrive. It is the world’s first dairy-free, allergen-free and environmentally friendly infant nutrition. Harmony Baby Nutrition was established in 2018 and is based in Boston, MA.

Gatehouse Bio

Seed Round in 2020
Gatehouse Bio is a biotech company based in Waltham, Massachusetts, founded in 2016. The company specializes in the development of therapies utilizing a novel bioinformatics platform that focuses on small ribonucleic acid (RNA) biomarkers. This platform is designed to classify patient samples with binary accuracy and identifies disease-associated mutations, enabling the creation of targeted therapeutics. By employing artificial intelligence, Gatehouse Bio aims to analyze small RNA genes and design oligonucleotides that can effectively counteract the effects of these mutations. Their research and development efforts target therapeutic areas with known heterogeneity, such as fibrosis, inflammation, and neurodegeneration, with the goal of unlocking the potential for improved patient outcomes through personalized medicine.

Pear Bio

Seed Round in 2020
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Pear Bio

Pre Seed Round in 2020
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

BioROSA Technologies

Convertible Note in 2020
BioROSA Technologies Inc. is a biotechnology company focused on developing diagnostic tools for Autism Spectrum Disorders (ASD). Founded in 2018 and headquartered in Belmont, Massachusetts, the company specializes in creating biologically-based blood tests that assist clinicians in identifying individuals at risk for ASD. By utilizing machine learning to analyze biological data, BioROSA Technologies aims to provide reliable and accurate diagnoses, facilitating early detection and timely treatment. Additionally, the company's technology supports therapeutic trials by evaluating pharmacodynamics and patient stratification, thereby enhancing the overall standard of care for ASD.

Pear Bio

Convertible Note in 2020
Pear Bio is a biotechnology company based in Boston and London that specializes in AI-enabled precision medicine for the treatment of challenging cancers. The company utilizes tumor biopsies and blood samples from cancer patients to identify new therapeutic targets through multi-omics analysis. Pear Bio's proprietary immune-microtumor platform allows for the testing of drug candidates directly on patient tumor samples, enhancing the efficacy of treatments. Additionally, the company employs a unique hydrogel technology that cultivates tumors outside the body, enabling the measurement of drug resistance and streamlining the treatment process. By focusing on tailored drug discovery and smarter combination therapies, Pear Bio aims to improve patient outcomes in cancer care.

Catalog

Series A in 2020
Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

Lura Health

Convertible Note in 2020
Lura Health is a pioneering company that has developed a non-invasive continuous health monitoring platform utilizing saliva as a diagnostic fluid. Founded in 2017 and headquartered in Cambridge, Massachusetts, the company focuses on chronic disease management, targeting conditions such as heart disease, chronic kidney disease, diabetes, and tooth decay. Lura Health's innovative sensors are designed to be integrated into patient-friendly orthodontic devices, including removable retainers and fixed brackets. These sensors continuously monitor oral acidity and other analytes in saliva, automatically transmitting valuable health data to a mobile application. This approach empowers users to track key diagnostic metrics within their oral environment, facilitating improved personal health management and potentially enhancing clinical outcomes.

Synthace

Venture Round in 2020
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Lura Health

Pre Seed Round in 2020
Lura Health is a pioneering company that has developed a non-invasive continuous health monitoring platform utilizing saliva as a diagnostic fluid. Founded in 2017 and headquartered in Cambridge, Massachusetts, the company focuses on chronic disease management, targeting conditions such as heart disease, chronic kidney disease, diabetes, and tooth decay. Lura Health's innovative sensors are designed to be integrated into patient-friendly orthodontic devices, including removable retainers and fixed brackets. These sensors continuously monitor oral acidity and other analytes in saliva, automatically transmitting valuable health data to a mobile application. This approach empowers users to track key diagnostic metrics within their oral environment, facilitating improved personal health management and potentially enhancing clinical outcomes.

Farma Genetix

Seed Round in 2019
Farma Genetix is a Boston-based company that specializes in manufacturing genetically tailored natural supplements and personalized diet plans aimed at addressing chronic health conditions. By collaborating with researchers from Harvard Medical School's Genomics department, Farma Genetix develops nutritional products designed to support cardiovascular health, including the maintenance of healthy blood pressure and cholesterol levels. The company emphasizes the importance of a customized dietary approach to promote overall well-being and reinforce a healthy lifestyle.

Mori

Seed Round in 2019
Mori, formerly known as Overlook Research, is a company that develops a natural biopolymer coating designed to extend the shelf life of perishable foods. Founded in 2016 and headquartered in Boston, Massachusetts, Mori's innovative coating is made from proteins extracted from natural silk using salt and water. This protective layer helps slow the spoiling process of various food items, including fruits, vegetables, meat, and seafood, thereby reducing food waste. By focusing on sustainable and economical solutions, Mori aims to transform the food supply and enhance the efficiency of the food, agriculture, and packaging industries.

BioROSA Technologies

Convertible Note in 2019
BioROSA Technologies Inc. is a biotechnology company focused on developing diagnostic tools for Autism Spectrum Disorders (ASD). Founded in 2018 and headquartered in Belmont, Massachusetts, the company specializes in creating biologically-based blood tests that assist clinicians in identifying individuals at risk for ASD. By utilizing machine learning to analyze biological data, BioROSA Technologies aims to provide reliable and accurate diagnoses, facilitating early detection and timely treatment. Additionally, the company's technology supports therapeutic trials by evaluating pharmacodynamics and patient stratification, thereby enhancing the overall standard of care for ASD.

Powerhouse Dynamics

Convertible Note in 2018
Powerhouse Dynamics, Inc. is a technology company specializing in enterprise energy and asset management systems tailored for small commercial facilities. Founded in 2008 and based in Newton, Massachusetts, the company offers the SiteSage platform, which centralizes the control, analysis, and management of energy-consuming equipment. This cloud-based system is designed to enhance operational efficiency through powerful analytics, providing users with insights via straightforward online and mobile interfaces. SiteSage continuously improves energy efficiency by monitoring power consumption, gas, and water usage, and it enables remote management of equipment such as HVAC systems. Additionally, the platform supports food safety and utility bill management, catering to a diverse client base that includes restaurants, convenience stores, and retail establishments. Powerhouse Dynamics operates as a subsidiary of The Middleby Corporation as of April 2019.

Synthace

Series B in 2018
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

ChefCharger

Seed Round in 2018
ChefCharger Inc. is a Boston-based company that specializes in the development, manufacturing, and sale of innovative charging devices tailored for the hospitality industry, including restaurants, bars, and cafes. Founded in 2016, the company offers integrated charging solutions that combine functionality with aesthetic appeal, featuring products such as candleholders, drink coasters, and customizable displays. These devices not only serve as tabletop accessories but also enable patrons to wirelessly charge their mobile phones while providing the establishment with a cloud-connected platform for displaying targeted video advertisements. Initially an MIT-based startup, ChefCharger has evolved into a mature smart device company, expanding its offerings to include charging solutions leveraging solar energy and custom engineering for various industries.

Powerhouse Dynamics

Convertible Note in 2018
Powerhouse Dynamics, Inc. is a technology company specializing in enterprise energy and asset management systems tailored for small commercial facilities. Founded in 2008 and based in Newton, Massachusetts, the company offers the SiteSage platform, which centralizes the control, analysis, and management of energy-consuming equipment. This cloud-based system is designed to enhance operational efficiency through powerful analytics, providing users with insights via straightforward online and mobile interfaces. SiteSage continuously improves energy efficiency by monitoring power consumption, gas, and water usage, and it enables remote management of equipment such as HVAC systems. Additionally, the platform supports food safety and utility bill management, catering to a diverse client base that includes restaurants, convenience stores, and retail establishments. Powerhouse Dynamics operates as a subsidiary of The Middleby Corporation as of April 2019.

BioROSA Technologies

Seed Round in 2018
BioROSA Technologies Inc. is a biotechnology company focused on developing diagnostic tools for Autism Spectrum Disorders (ASD). Founded in 2018 and headquartered in Belmont, Massachusetts, the company specializes in creating biologically-based blood tests that assist clinicians in identifying individuals at risk for ASD. By utilizing machine learning to analyze biological data, BioROSA Technologies aims to provide reliable and accurate diagnoses, facilitating early detection and timely treatment. Additionally, the company's technology supports therapeutic trials by evaluating pharmacodynamics and patient stratification, thereby enhancing the overall standard of care for ASD.

Synthace

Series A in 2018
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Bitome

Convertible Note in 2018
Bitome is a Boston-based connected medical device company focused on developing innovative monitoring solutions. Founded two years ago, it has created a noninvasive tool for assessing hydration status, which has significant applications in various fields, including dialysis, diabetes management, sports performance, and maternal/fetal health. The company's initial application targets patients with congestive heart failure (CHF), allowing for precise monitoring of volume status—an important yet challenging biometric to measure that is closely linked to patient outcomes. Bitome aims to revolutionize hydration monitoring in a manner comparable to the impact glucose monitoring has had on diabetes care.

Powerhouse Dynamics

Convertible Note in 2018
Powerhouse Dynamics, Inc. is a technology company specializing in enterprise energy and asset management systems tailored for small commercial facilities. Founded in 2008 and based in Newton, Massachusetts, the company offers the SiteSage platform, which centralizes the control, analysis, and management of energy-consuming equipment. This cloud-based system is designed to enhance operational efficiency through powerful analytics, providing users with insights via straightforward online and mobile interfaces. SiteSage continuously improves energy efficiency by monitoring power consumption, gas, and water usage, and it enables remote management of equipment such as HVAC systems. Additionally, the platform supports food safety and utility bill management, catering to a diverse client base that includes restaurants, convenience stores, and retail establishments. Powerhouse Dynamics operates as a subsidiary of The Middleby Corporation as of April 2019.

Mori

Seed Round in 2017
Mori, formerly known as Overlook Research, is a company that develops a natural biopolymer coating designed to extend the shelf life of perishable foods. Founded in 2016 and headquartered in Boston, Massachusetts, Mori's innovative coating is made from proteins extracted from natural silk using salt and water. This protective layer helps slow the spoiling process of various food items, including fruits, vegetables, meat, and seafood, thereby reducing food waste. By focusing on sustainable and economical solutions, Mori aims to transform the food supply and enhance the efficiency of the food, agriculture, and packaging industries.

Synthace

Series A in 2017
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

Prospective Research

Seed Round in 2017
Prospective Research, Inc., based in Beverly, Massachusetts, specializes in developing innovative solutions for antibiotic discovery and disease management in aquaculture. Founded in 2015, the company utilizes its proprietary MicrobeMiner platform to access untapped antibiotics by mimicking natural soil stimuli. Its GeneMiner technology aligns specific microbes with targeted stimuli, while the StimKeys technology reproduces these stimuli to unlock microbial natural products. Additionally, Prospective Research is pioneering feed-integrated preventative disease management solutions that eliminate the need for traditional antibiotics in aquaculture. By employing microbial signaling molecules, the company can modulate bacterial behavior and deliver therapeutics directly to the gut of farmed species. Prospective Research introduces trillions of beneficial bacteria into the microbiome of fin-fish, shrimp, and shellfish, enabling selective activation of bacterial genes that produce bio-active therapeutics to combat various pathogens.

Catalog

Seed Round in 2017
Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

Prospective Research

Seed Round in 2017
Prospective Research, Inc., based in Beverly, Massachusetts, specializes in developing innovative solutions for antibiotic discovery and disease management in aquaculture. Founded in 2015, the company utilizes its proprietary MicrobeMiner platform to access untapped antibiotics by mimicking natural soil stimuli. Its GeneMiner technology aligns specific microbes with targeted stimuli, while the StimKeys technology reproduces these stimuli to unlock microbial natural products. Additionally, Prospective Research is pioneering feed-integrated preventative disease management solutions that eliminate the need for traditional antibiotics in aquaculture. By employing microbial signaling molecules, the company can modulate bacterial behavior and deliver therapeutics directly to the gut of farmed species. Prospective Research introduces trillions of beneficial bacteria into the microbiome of fin-fish, shrimp, and shellfish, enabling selective activation of bacterial genes that produce bio-active therapeutics to combat various pathogens.

Bitome

Convertible Note in 2016
Bitome is a Boston-based connected medical device company focused on developing innovative monitoring solutions. Founded two years ago, it has created a noninvasive tool for assessing hydration status, which has significant applications in various fields, including dialysis, diabetes management, sports performance, and maternal/fetal health. The company's initial application targets patients with congestive heart failure (CHF), allowing for precise monitoring of volume status—an important yet challenging biometric to measure that is closely linked to patient outcomes. Bitome aims to revolutionize hydration monitoring in a manner comparable to the impact glucose monitoring has had on diabetes care.

Catalog

Pre Seed Round in 2016
Catalog Technologies Inc. specializes in a DNA-based platform that revolutionizes digital data storage and computation. Founded in 2016 and headquartered in Boston, Massachusetts, the company provides a method for encoding digital information into DNA, making it a viable and cost-effective solution for long-term data archiving. By leveraging advanced synthetic biology technologies, Catalog aims to transform how information is stored, allowing customers to utilize DNA molecules as a primary medium for digital records. This innovative approach positions Catalog at the forefront of next-generation data storage solutions.

Speedy Packets

Convertible Note in 2016
Speedy Packets, Inc. is a technology company based in Cambridge, Massachusetts, specializing in cloud-based software solutions aimed at optimizing internet performance. Founded in 2013, the company has developed a unique, patent-pending technology that enhances TCP performance across various types of connections, including fiber, DSL, wireless, and satellite networks. By applying innovative coding techniques to blocks of TCP packets, Speedy Packets' software effectively reduces packet loss and the need for retransmission requests, resulting in significant improvements in overall throughput and internet speed. This advancement allows businesses, service providers, and individual users to enjoy a more reliable and high-quality online experience, facilitating seamless streaming, file transfers, and content sharing.

Powerhouse Dynamics

Convertible Note in 2016
Powerhouse Dynamics, Inc. is a technology company specializing in enterprise energy and asset management systems tailored for small commercial facilities. Founded in 2008 and based in Newton, Massachusetts, the company offers the SiteSage platform, which centralizes the control, analysis, and management of energy-consuming equipment. This cloud-based system is designed to enhance operational efficiency through powerful analytics, providing users with insights via straightforward online and mobile interfaces. SiteSage continuously improves energy efficiency by monitoring power consumption, gas, and water usage, and it enables remote management of equipment such as HVAC systems. Additionally, the platform supports food safety and utility bill management, catering to a diverse client base that includes restaurants, convenience stores, and retail establishments. Powerhouse Dynamics operates as a subsidiary of The Middleby Corporation as of April 2019.

Bitome

Seed Round in 2016
Bitome is a Boston-based connected medical device company focused on developing innovative monitoring solutions. Founded two years ago, it has created a noninvasive tool for assessing hydration status, which has significant applications in various fields, including dialysis, diabetes management, sports performance, and maternal/fetal health. The company's initial application targets patients with congestive heart failure (CHF), allowing for precise monitoring of volume status—an important yet challenging biometric to measure that is closely linked to patient outcomes. Bitome aims to revolutionize hydration monitoring in a manner comparable to the impact glucose monitoring has had on diabetes care.

Prospective Research

Seed Round in 2016
Prospective Research, Inc., based in Beverly, Massachusetts, specializes in developing innovative solutions for antibiotic discovery and disease management in aquaculture. Founded in 2015, the company utilizes its proprietary MicrobeMiner platform to access untapped antibiotics by mimicking natural soil stimuli. Its GeneMiner technology aligns specific microbes with targeted stimuli, while the StimKeys technology reproduces these stimuli to unlock microbial natural products. Additionally, Prospective Research is pioneering feed-integrated preventative disease management solutions that eliminate the need for traditional antibiotics in aquaculture. By employing microbial signaling molecules, the company can modulate bacterial behavior and deliver therapeutics directly to the gut of farmed species. Prospective Research introduces trillions of beneficial bacteria into the microbiome of fin-fish, shrimp, and shellfish, enabling selective activation of bacterial genes that produce bio-active therapeutics to combat various pathogens.

Crowdly

Venture Round in 2016
Crowdly is an advocate marketing platform based in Boston, Massachusetts, founded in 2011. The company specializes in connecting large consumer brands with their authentic advocates, facilitating the activation of these advocates to enhance word-of-mouth promotion and brand advocacy. By leveraging its platform, Crowdly enables brands to understand advocate behavior, which in turn helps them drive stronger branding and achieve a greater return on investment. The company's focus spans various sectors, including finance, social media, advertising, and social media marketing, positioning it as a key player in the advocate marketing landscape.

Powerhouse Dynamics

Convertible Note in 2016
Powerhouse Dynamics, Inc. is a technology company specializing in enterprise energy and asset management systems tailored for small commercial facilities. Founded in 2008 and based in Newton, Massachusetts, the company offers the SiteSage platform, which centralizes the control, analysis, and management of energy-consuming equipment. This cloud-based system is designed to enhance operational efficiency through powerful analytics, providing users with insights via straightforward online and mobile interfaces. SiteSage continuously improves energy efficiency by monitoring power consumption, gas, and water usage, and it enables remote management of equipment such as HVAC systems. Additionally, the platform supports food safety and utility bill management, catering to a diverse client base that includes restaurants, convenience stores, and retail establishments. Powerhouse Dynamics operates as a subsidiary of The Middleby Corporation as of April 2019.

Speedy Packets

Convertible Note in 2016
Speedy Packets, Inc. is a technology company based in Cambridge, Massachusetts, specializing in cloud-based software solutions aimed at optimizing internet performance. Founded in 2013, the company has developed a unique, patent-pending technology that enhances TCP performance across various types of connections, including fiber, DSL, wireless, and satellite networks. By applying innovative coding techniques to blocks of TCP packets, Speedy Packets' software effectively reduces packet loss and the need for retransmission requests, resulting in significant improvements in overall throughput and internet speed. This advancement allows businesses, service providers, and individual users to enjoy a more reliable and high-quality online experience, facilitating seamless streaming, file transfers, and content sharing.

Miramix

Seed Round in 2015
Miramix is a Massachusetts-based company that specializes in producing customized nutritional supplements tailored to individual health goals. It operates a marketplace that enables consumers to create their own supplement blends using micro-dosing technology, allowing for precise formulation milligram by milligram. The product offerings include custom supplements, branded supplements, private label supplements, workout supplements, and beauty supplements, catering to a diverse array of dietary needs. By providing both the hardware and software tools necessary for individuals to develop bespoke capsules, Miramix aims to empower consumers to find the optimal nutrient combinations that support their personal health objectives.

Prospective Research

Seed Round in 2015
Prospective Research, Inc., based in Beverly, Massachusetts, specializes in developing innovative solutions for antibiotic discovery and disease management in aquaculture. Founded in 2015, the company utilizes its proprietary MicrobeMiner platform to access untapped antibiotics by mimicking natural soil stimuli. Its GeneMiner technology aligns specific microbes with targeted stimuli, while the StimKeys technology reproduces these stimuli to unlock microbial natural products. Additionally, Prospective Research is pioneering feed-integrated preventative disease management solutions that eliminate the need for traditional antibiotics in aquaculture. By employing microbial signaling molecules, the company can modulate bacterial behavior and deliver therapeutics directly to the gut of farmed species. Prospective Research introduces trillions of beneficial bacteria into the microbiome of fin-fish, shrimp, and shellfish, enabling selective activation of bacterial genes that produce bio-active therapeutics to combat various pathogens.

Harmonix Music Systems

Venture Round in 2015
Harmonix Music Systems, Inc. is a video game development studio based in Cambridge, Massachusetts, founded in 1995 by Alex Rigopulos and Eran Egozy. The company specializes in creating music-oriented video games that allow users to engage with music through gameplay across various platforms, including console, PC, and mobile. Harmonix is well-known for its successful franchises, such as Rock Band and Dance Central, and was the original developer of the Guitar Hero series up until Guitar Hero III: Legends of Rock. The studio focuses on providing interactive entertainment that enables players, regardless of musical background, to experience the joy of making music.

Speedy Packets

Venture Round in 2015
Speedy Packets, Inc. is a technology company based in Cambridge, Massachusetts, specializing in cloud-based software solutions aimed at optimizing internet performance. Founded in 2013, the company has developed a unique, patent-pending technology that enhances TCP performance across various types of connections, including fiber, DSL, wireless, and satellite networks. By applying innovative coding techniques to blocks of TCP packets, Speedy Packets' software effectively reduces packet loss and the need for retransmission requests, resulting in significant improvements in overall throughput and internet speed. This advancement allows businesses, service providers, and individual users to enjoy a more reliable and high-quality online experience, facilitating seamless streaming, file transfers, and content sharing.

Crowdly

Venture Round in 2015
Crowdly is an advocate marketing platform based in Boston, Massachusetts, founded in 2011. The company specializes in connecting large consumer brands with their authentic advocates, facilitating the activation of these advocates to enhance word-of-mouth promotion and brand advocacy. By leveraging its platform, Crowdly enables brands to understand advocate behavior, which in turn helps them drive stronger branding and achieve a greater return on investment. The company's focus spans various sectors, including finance, social media, advertising, and social media marketing, positioning it as a key player in the advocate marketing landscape.

The Tap Lab

Venture Round in 2015
The Tap Lab is a Cambridge, Massachusetts-based social mobile gaming company that develops ambitious mobile games designed for a new generation of gamers. Their games innovatively explore novel ways for players to interact with their surroundings and integrate gameplay into the real world, fostering imagination and creativity among users.

Cobalt Software

Venture Round in 2015
Cobalt Software, Inc. is a financial technology company based in Boston, Massachusetts, that specializes in developing software solutions for private equity and venture capital firms. Founded in 2011, the company offers tools that enable clients to collect, analyze, and report on fund and portfolio company metrics tailored to their specific needs. Its product offerings include the Fund Launch, which validates performance track records for potential investors; the Performance Calculator, which assesses fund and portfolio performance against peers and market benchmarks; and the Deal Calculator, which analyzes operational changes in portfolio companies and their impact on returns. Cobalt Software's platform enhances performance reporting, cash flow tracking, manager selection, and benchmarking, facilitating effective communication between general partners and limited partners. The company has established a strategic partnership with Hamilton Lane to further enhance its service offerings.

Synthace

Series A in 2014
Synthace Limited is a London-based company specializing in the development and operation of software solutions for various industries, including health, pharmaceuticals, food, energy, agri-science, industrial biotechnology, and manufacturing. The company offers Antha, a cloud-based platform designed to automate and enhance biological processes. This platform allows life science researchers to digitize experiments from start to finish, enabling them to design, simulate, and execute reproducible experiments with minimal training. Antha facilitates the integration of experimental data and metadata in a streamlined manner, making it easier for scientists to manage their workflows and increasing the scientific value of their research. Synthace's technology empowers researchers to conduct complex experiments without the need for coding, thereby expanding the possibilities of laboratory experimentation. Founded in 2011, Synthace also has a presence in Cambridge, Massachusetts, and maintains a strategic partnership with Microsoft.

The Tap Lab

Seed Round in 2014
The Tap Lab is a Cambridge, Massachusetts-based social mobile gaming company that develops ambitious mobile games designed for a new generation of gamers. Their games innovatively explore novel ways for players to interact with their surroundings and integrate gameplay into the real world, fostering imagination and creativity among users.

Powerhouse Dynamics

Series B in 2014
Powerhouse Dynamics, Inc. is a technology company specializing in enterprise energy and asset management systems tailored for small commercial facilities. Founded in 2008 and based in Newton, Massachusetts, the company offers the SiteSage platform, which centralizes the control, analysis, and management of energy-consuming equipment. This cloud-based system is designed to enhance operational efficiency through powerful analytics, providing users with insights via straightforward online and mobile interfaces. SiteSage continuously improves energy efficiency by monitoring power consumption, gas, and water usage, and it enables remote management of equipment such as HVAC systems. Additionally, the platform supports food safety and utility bill management, catering to a diverse client base that includes restaurants, convenience stores, and retail establishments. Powerhouse Dynamics operates as a subsidiary of The Middleby Corporation as of April 2019.

Formlabs

Series A in 2013
Formlabs Inc. is a company that designs and manufactures advanced 3D printing systems targeted at engineers, designers, and artists. Established in 2011 and headquartered in Somerville, Massachusetts, Formlabs offers a diverse range of products, including the Form 3, Form 3B, and Form 3L printers, all utilizing Low Force Stereolithography (LFS) technology. The company also provides post-processing solutions such as Form Wash and Form Cure, as well as the Fuse 1 SLS 3D printer and the Form Cell manufacturing solution. Formlabs develops high-performance materials for various applications in industries like dental, healthcare, jewelry, and education. Its PreForm software facilitates the preparation of models for printing, making it a preferred choice among professionals worldwide. With additional offices in Germany, Japan, China, Singapore, Hungary, and North Carolina, Formlabs continues to innovate in the field of 3D printing, enhancing the capabilities of digital fabrication.

Collaborate.com

Seed Round in 2011
Collaborate.com is a cloud-based team collaboration platform designed to enhance communication and productivity for mobile workforces. Founded in 2011 by entrepreneurs Matt Cutler and David Greenstein, the platform integrates messaging, document sharing, and task management within a single mobile application compatible with iPhone, Android, and the Web. It offers seamless integration with popular cloud services, allowing teams to easily share and manage documents. Users can quickly get started with Collaborate.com by accessing its website or downloading the app from app stores. The company is based in Boston and operates under Kibits Corp.

Formlabs

Seed Round in 2011
Formlabs Inc. is a company that designs and manufactures advanced 3D printing systems targeted at engineers, designers, and artists. Established in 2011 and headquartered in Somerville, Massachusetts, Formlabs offers a diverse range of products, including the Form 3, Form 3B, and Form 3L printers, all utilizing Low Force Stereolithography (LFS) technology. The company also provides post-processing solutions such as Form Wash and Form Cure, as well as the Fuse 1 SLS 3D printer and the Form Cell manufacturing solution. Formlabs develops high-performance materials for various applications in industries like dental, healthcare, jewelry, and education. Its PreForm software facilitates the preparation of models for printing, making it a preferred choice among professionals worldwide. With additional offices in Germany, Japan, China, Singapore, Hungary, and North Carolina, Formlabs continues to innovate in the field of 3D printing, enhancing the capabilities of digital fabrication.

Powerhouse Dynamics

Series A in 2011
Powerhouse Dynamics, Inc. is a technology company specializing in enterprise energy and asset management systems tailored for small commercial facilities. Founded in 2008 and based in Newton, Massachusetts, the company offers the SiteSage platform, which centralizes the control, analysis, and management of energy-consuming equipment. This cloud-based system is designed to enhance operational efficiency through powerful analytics, providing users with insights via straightforward online and mobile interfaces. SiteSage continuously improves energy efficiency by monitoring power consumption, gas, and water usage, and it enables remote management of equipment such as HVAC systems. Additionally, the platform supports food safety and utility bill management, catering to a diverse client base that includes restaurants, convenience stores, and retail establishments. Powerhouse Dynamics operates as a subsidiary of The Middleby Corporation as of April 2019.

Collaborate.com

Seed Round in 2011
Collaborate.com is a cloud-based team collaboration platform designed to enhance communication and productivity for mobile workforces. Founded in 2011 by entrepreneurs Matt Cutler and David Greenstein, the platform integrates messaging, document sharing, and task management within a single mobile application compatible with iPhone, Android, and the Web. It offers seamless integration with popular cloud services, allowing teams to easily share and manage documents. Users can quickly get started with Collaborate.com by accessing its website or downloading the app from app stores. The company is based in Boston and operates under Kibits Corp.

SocialSci

Angel Round in 2010
SocialSci is an online platform tailored for academic researchers to conduct scientific surveys and in-lab studies. Founded in 2009 and based in Cambridge, Massachusetts, the platform facilitates the design of surveys through an intuitive drag-and-drop interface, allowing users to create and manage unlimited surveys and responses. It also features a built-in recruitment system that incentivizes participation through a point system while effectively screening out repeat participants. SocialSci is utilized by colleges and universities across the United States, bridging the gap between traditional research methods and modern technological practices in participant recruitment and data collection.

Powerhouse Dynamics

Venture Round in 2010
Powerhouse Dynamics, Inc. is a technology company specializing in enterprise energy and asset management systems tailored for small commercial facilities. Founded in 2008 and based in Newton, Massachusetts, the company offers the SiteSage platform, which centralizes the control, analysis, and management of energy-consuming equipment. This cloud-based system is designed to enhance operational efficiency through powerful analytics, providing users with insights via straightforward online and mobile interfaces. SiteSage continuously improves energy efficiency by monitoring power consumption, gas, and water usage, and it enables remote management of equipment such as HVAC systems. Additionally, the platform supports food safety and utility bill management, catering to a diverse client base that includes restaurants, convenience stores, and retail establishments. Powerhouse Dynamics operates as a subsidiary of The Middleby Corporation as of April 2019.

Harmonix Music Systems

Venture Round in 1998
Harmonix Music Systems, Inc. is a video game development studio based in Cambridge, Massachusetts, founded in 1995 by Alex Rigopulos and Eran Egozy. The company specializes in creating music-oriented video games that allow users to engage with music through gameplay across various platforms, including console, PC, and mobile. Harmonix is well-known for its successful franchises, such as Rock Band and Dance Central, and was the original developer of the Guitar Hero series up until Guitar Hero III: Legends of Rock. The studio focuses on providing interactive entertainment that enables players, regardless of musical background, to experience the joy of making music.

Harmonix Music Systems

Venture Round in 1996
Harmonix Music Systems, Inc. is a video game development studio based in Cambridge, Massachusetts, founded in 1995 by Alex Rigopulos and Eran Egozy. The company specializes in creating music-oriented video games that allow users to engage with music through gameplay across various platforms, including console, PC, and mobile. Harmonix is well-known for its successful franchises, such as Rock Band and Dance Central, and was the original developer of the Guitar Hero series up until Guitar Hero III: Legends of Rock. The studio focuses on providing interactive entertainment that enables players, regardless of musical background, to experience the joy of making music.

NetGenesis

Venture Round in 1995
Net.Genesis Corp. provides software and professional services that help its customers understand, analyze and improve their online businesses. Its software enables companies to collect, store, organize, and analyze detailed information about the online behavior of customers and other visitors on their web sites. Net.Genesis software also enables its customers to import and analyze information about e-customers from other online and off-line software systems and databases. In addition, the company offers professional services including strategic analytic consulting, product implementation, application integration, training programs, and technical support services. The company markets its products and related services in United States, Europe, and Australia. It was founded in 1994 and is headquartered in Cambridge, Massachusetts. As of December 21, 2001, net.Genesis Corp. was acquired by SPSS Inc.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.